Julia Czerwik
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Julia Czerwik has a total of 38 co-authors. Here are the top co-authors by number of shared publications:
- Joanna Dmochowska
The University Clinical Centre, Gdańsk, Poland
5 shared publications - Julia Kuszneruk
Medical University of Lublin, Poland
5 shared publications - Katarzyna Krzemińska
Medical University of Lublin, Poland
5 shared publications - Maria Kubas
Medical University of Lublin, Poland
5 shared publications - Marta Czubala
Medical University of Lublin
5 shared publications - Joanna Cieszkowska
Uniwersytet Medyczny w Lublinie
4 shared publications
Latest Publications
- Open Access
- 12 March 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Pedagogy and Psychology of Sport
- Vol. 30, 69262
Eating Disorders in Athletes: A Systematic Review
Eating disorders (EDs) represent a critical and complex issue in sports, particularly among athletes exposed to high-performance demands and appearance-related pressures. Athletic participation is generally associated with health and psychological benefits. However, certain environments increase the risk of developing disordered eating (DE) behaviors. This systematic review examines the epidemiology and risk factors associated with EDs in athletic populations. It focuses particularly on high-risk groups such as female athletes and participants in leanness-focused sports. It introduces a developing understanding of low energy availability, as conceptualized in the Female Athlete Triad and the broader Relative Energy Deficiency in Sport (RED-S) model. The review outlines the multi-system health consequences of RED-S, including effects on reproductive, cardiovascular, immune, and psychological function. Moreover, it highlights the diagnostic challenges in sports settings, where restrictive eating is often normalized or hidden. Finally, the review synthesizes current evidence on clinical management, treatment strategies, and the importance of educational and preventive interventions within sport environments to protect athlete health and performance. Comprehensive awareness and early multidisciplinary interventions are essential for addressing EDs and supporting sustainable athletic careers.
- 12 March 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Pedagogy and Psychology of Sport
- Vol. 30, 69262
Open AccessEating Disorders in Athletes: A Systematic Review
Eating disorders (EDs) represent a critical and complex issue in sports, particularly among athletes exposed to high-performance demands and appearance-related pressures. Athletic participation is generally associated with health and psychological benefits. However, certain environments increase the risk of developing disordered eating (DE) behaviors. This systematic review examines the epidemiology and risk factors associated with EDs in athletic populations. It focuses particularly on high-risk groups such as female athletes and participants in leanness-focused sports. It introduces a developing understanding of low energy availability, as conceptualized in the Female Athlete Triad and the broader Relative Energy Deficiency in Sport (RED-S) model. The review outlines the multi-system health consequences of RED-S, including effects on reproductive, cardiovascular, immune, and psychological function. Moreover, it highlights the diagnostic challenges in sports settings, where restrictive eating is often normalized or hidden. Finally, the review synthesizes current evidence on clinical management, treatment strategies, and the importance of educational and preventive interventions within sport environments to protect athlete health and performance. Comprehensive awareness and early multidisciplinary interventions are essential for addressing EDs and supporting sustainable athletic careers.
- Open Access
- 30 September 2025
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 6 (3(47))
MANAGEMENT OF ACUTE LIMB ISCHEMIA - THE REVIEW
Acute limb ischemia (ALI) is a sudden reduction in limb perfusion that threatens limb viability and requires urgent intervention. It can present as an acute manifestation of peripheral arterial disease (PAD) or as an acute event in previously asymptomatic patients. This review outlines the epidemiology, pathophysiology, clinical features, diagnostic approaches, and current treatment strategies for ALI. Emphasis is placed on differentiating thrombotic and embolic causes, the use of imaging modalities such as CT angiography and duplex ultrasonography, and the application of the Rutherford classification to guide treatment decisions. Immediate systemic anticoagulation remains the cornerstone of early management, followed by either surgical revascularization or endovascular therapies. While open surgery remains standard in many cases, newer percutaneous mechanical thrombectomy systems (PMT) have emerged as effective alternatives, particularly in patients with contraindications to surgery or thrombolysis. Despite advances in diagnosis and therapy, ALI continues to carry a high risk of amputation and mortality.
- 30 September 2025
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 6 (3(47))
Open AccessMANAGEMENT OF ACUTE LIMB ISCHEMIA - THE REVIEW
Acute limb ischemia (ALI) is a sudden reduction in limb perfusion that threatens limb viability and requires urgent intervention. It can present as an acute manifestation of peripheral arterial disease (PAD) or as an acute event in previously asymptomatic patients. This review outlines the epidemiology, pathophysiology, clinical features, diagnostic approaches, and current treatment strategies for ALI. Emphasis is placed on differentiating thrombotic and embolic causes, the use of imaging modalities such as CT angiography and duplex ultrasonography, and the application of the Rutherford classification to guide treatment decisions. Immediate systemic anticoagulation remains the cornerstone of early management, followed by either surgical revascularization or endovascular therapies. While open surgery remains standard in many cases, newer percutaneous mechanical thrombectomy systems (PMT) have emerged as effective alternatives, particularly in patients with contraindications to surgery or thrombolysis. Despite advances in diagnosis and therapy, ALI continues to carry a high risk of amputation and mortality.
- Open Access
- 29 September 2025
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 4 (3(47))
A MULTIDISCIPLINARY APPROACH TO THE TREATMENT OF CHRONIC PANCREATITIS
Chronic pancreatitis (CP) is a progressive inflammatory disease of the pancreas that leads to irreversible structural damage, abdominal pain, and exocrine and endocrine insufficiency. Its etiology is multifactorial, with alcohol consumption and cigarette smoking representing the most significant modifiable risk factors, while genetic, autoimmune, and metabolic mechanisms are increasingly recognized. The aim of this review was to summarize current knowledge on the pathogenesis, diagnosis, and management of CP, with particular emphasis on the importance of an interdisciplinary approach. A comprehensive literature focused on original studies, clinical guidelines, and meta-analyses published in the last 15 years. Effective management of CP requires a stepwise strategy, beginning with lifestyle modification, pain control, pancreatic enzyme replacement therapy, and management of diabetes. Endoscopic and surgical procedures are reserved for patients with refractory symptoms, with duodenum-preserving techniques demonstrating favorable outcomes in pain relief, pancreatic function preservation, and quality of life. In advanced disease, surgical management provides superior long-term results compared with endoscopy. In addition, psychological care has emerged as an integral part of management, addressing the burden of chronic pain, comorbid depression, and addictive behaviors. Nutritional support, including adequate enzyme supplementation and correction of fat-soluble vitamin deficiencies, remains essential to prevent malnutrition and osteoporosis. In conclusion, CP is a complex disorder requiring multidisciplinary care. Early recognition of risk factors, combined with individualized therapeutic strategies and integration of medical, surgical, and psychosocial interventions, is fundamental to improving patient prognosis and quality of life.
- 29 September 2025
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 4 (3(47))
Open AccessA MULTIDISCIPLINARY APPROACH TO THE TREATMENT OF CHRONIC PANCREATITIS
Chronic pancreatitis (CP) is a progressive inflammatory disease of the pancreas that leads to irreversible structural damage, abdominal pain, and exocrine and endocrine insufficiency. Its etiology is multifactorial, with alcohol consumption and cigarette smoking representing the most significant modifiable risk factors, while genetic, autoimmune, and metabolic mechanisms are increasingly recognized. The aim of this review was to summarize current knowledge on the pathogenesis, diagnosis, and management of CP, with particular emphasis on the importance of an interdisciplinary approach. A comprehensive literature focused on original studies, clinical guidelines, and meta-analyses published in the last 15 years. Effective management of CP requires a stepwise strategy, beginning with lifestyle modification, pain control, pancreatic enzyme replacement therapy, and management of diabetes. Endoscopic and surgical procedures are reserved for patients with refractory symptoms, with duodenum-preserving techniques demonstrating favorable outcomes in pain relief, pancreatic function preservation, and quality of life. In advanced disease, surgical management provides superior long-term results compared with endoscopy. In addition, psychological care has emerged as an integral part of management, addressing the burden of chronic pain, comorbid depression, and addictive behaviors. Nutritional support, including adequate enzyme supplementation and correction of fat-soluble vitamin deficiencies, remains essential to prevent malnutrition and osteoporosis. In conclusion, CP is a complex disorder requiring multidisciplinary care. Early recognition of risk factors, combined with individualized therapeutic strategies and integration of medical, surgical, and psychosocial interventions, is fundamental to improving patient prognosis and quality of life.
- Open Access
- 24 September 2025
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 4 (3(47))
CEREBELLAR LIPONEUROCYTOMA IN THE LAST DECADE: A COMPREHENSIVE CASE REVIEW
Introduction. Tumors of the central nervous system (CNS) are relatively uncommon when compared with neoplasms arising in other organs and tissues of the human body. Among these rare entities, cerebellar liponeurocytoma represents one of the least frequently encountered tumor types. This neoplasm was originally described in 1978 by Bechtel and colleagues, who referred to it as a “mixed mesenchymal and neuroectodermal tumor” due to its unusual histological characteristics combining neuronal and lipomatous differentiation. Since that time, only a limited number of cases have been reported in the literature, underlining its exceptional rarity. In subsequent decades, advances in neuropathology and molecular diagnostics have allowed for more precise recognition of this lesion as a distinct clinicopathological entity. Within the World Health Organization (WHO) classification of tumors of the central nervous system published in 2016, cerebellar liponeurocytoma was formally designated as a grade II tumor. This reflects its generally indolent biological behavior but also acknowledges the significant potential for local recurrence following treatment. Aim of the Study. The aim of the study was to collect data about symptoms and immunoreactivity of cerebellar liponeurocytoma from published cases between 2014 and 2024. Materials and Methods. PubMed and Scopus databases were used to search for cerebellar liponeurocytoma cases. Result. Analyzing data from 32 cases of cerebellar liponeurocytoma, 11 men (34.4%) and 21 women (65.6%) were affected. The mean age was 42.9 ± 18.17 years. The youngest person was 6 years old and the oldest was 77. Two cases concerned patients under 18 years old. The most common tumor location was the posterior fossa (25/32 cases, 78.12%), followed by the ventricle area (4 cases, 12.5%) and the frontal lobe (1 case). The most common symptoms were headache (26/32, 81.25%), vomiting and nausea (15/32, 46.9%), gait disturbance (14/32, 44%), ataxia (3/32, 9.4%), paresthesia (3/32, 9.4%), and urge incontinence (1 case). Conclusion. Cerebellar liponeurocytoma is a rare but distinctive tumor of the central nervous system. The usual symptoms arise from the tumor's typical location in the cerebellum. Its clinical course, with atypical features, may pose significant management challenges. Further research into the tumor's molecular and genetic characteristics is needed to provide insights into optimizing management strategies and improving patient outcomes.
- 24 September 2025
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 4 (3(47))
Open AccessCEREBELLAR LIPONEUROCYTOMA IN THE LAST DECADE: A COMPREHENSIVE CASE REVIEW
Introduction. Tumors of the central nervous system (CNS) are relatively uncommon when compared with neoplasms arising in other organs and tissues of the human body. Among these rare entities, cerebellar liponeurocytoma represents one of the least frequently encountered tumor types. This neoplasm was originally described in 1978 by Bechtel and colleagues, who referred to it as a “mixed mesenchymal and neuroectodermal tumor” due to its unusual histological characteristics combining neuronal and lipomatous differentiation. Since that time, only a limited number of cases have been reported in the literature, underlining its exceptional rarity. In subsequent decades, advances in neuropathology and molecular diagnostics have allowed for more precise recognition of this lesion as a distinct clinicopathological entity. Within the World Health Organization (WHO) classification of tumors of the central nervous system published in 2016, cerebellar liponeurocytoma was formally designated as a grade II tumor. This reflects its generally indolent biological behavior but also acknowledges the significant potential for local recurrence following treatment. Aim of the Study. The aim of the study was to collect data about symptoms and immunoreactivity of cerebellar liponeurocytoma from published cases between 2014 and 2024. Materials and Methods. PubMed and Scopus databases were used to search for cerebellar liponeurocytoma cases. Result. Analyzing data from 32 cases of cerebellar liponeurocytoma, 11 men (34.4%) and 21 women (65.6%) were affected. The mean age was 42.9 ± 18.17 years. The youngest person was 6 years old and the oldest was 77. Two cases concerned patients under 18 years old. The most common tumor location was the posterior fossa (25/32 cases, 78.12%), followed by the ventricle area (4 cases, 12.5%) and the frontal lobe (1 case). The most common symptoms were headache (26/32, 81.25%), vomiting and nausea (15/32, 46.9%), gait disturbance (14/32, 44%), ataxia (3/32, 9.4%), paresthesia (3/32, 9.4%), and urge incontinence (1 case). Conclusion. Cerebellar liponeurocytoma is a rare but distinctive tumor of the central nervous system. The usual symptoms arise from the tumor's typical location in the cerebellum. Its clinical course, with atypical features, may pose significant management challenges. Further research into the tumor's molecular and genetic characteristics is needed to provide insights into optimizing management strategies and improving patient outcomes.
- Open Access
- 12 September 2025
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 2 (3(47))
HPV AND ANAL CANCER: GLOBAL PATTERNS, KEY RISK FACTORS, AND ADVANCES IN PREVENTION
Introduction and Purpose: This article comprehensively analyzes human papillomavirus (HPV) in anal cancer, covering its epidemiology, etiology, risk factors, and role in anal squamous cell carcinoma. Methods: A literature search of PubMed and Google Scholar (2020–2025) included observational studies, clinical trials, meta-analyses, and systematic reviews. State of Knowledge: HPV is the main cause of anal squamous cell carcinoma (ASCC), whose incidence is rising in high-income countries and is highest in men who have sex with men (MSM), people with HIV, and those with multiple partners, immunosuppression, receptive anal intercourse, smoking, or co-infections. Over 80% of ASCC cases are linked to HPV16, with HPV-positive cancers showing better survival, yet despite the vaccine being nearly 100% effective if given before sexual debut, global uptake remains low. Conclusion: Persistent infection with high-risk HPV, especially HPV16, is the main driver of anal carcinogenesis, paralleling cervical disease, and HPV-driven anal cancer is an increasing public health concern. To reduce the incidence and improve outcomes, expanded vaccination, targeted screening, and public awareness are essential. Future efforts should focus on enhancing prevention uptake, clarifying the significance of HPV16 sublineages, and evaluating co-infections and immunity to improve prevention and management.
- 12 September 2025
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 2 (3(47))
Open AccessHPV AND ANAL CANCER: GLOBAL PATTERNS, KEY RISK FACTORS, AND ADVANCES IN PREVENTION
Introduction and Purpose: This article comprehensively analyzes human papillomavirus (HPV) in anal cancer, covering its epidemiology, etiology, risk factors, and role in anal squamous cell carcinoma. Methods: A literature search of PubMed and Google Scholar (2020–2025) included observational studies, clinical trials, meta-analyses, and systematic reviews. State of Knowledge: HPV is the main cause of anal squamous cell carcinoma (ASCC), whose incidence is rising in high-income countries and is highest in men who have sex with men (MSM), people with HIV, and those with multiple partners, immunosuppression, receptive anal intercourse, smoking, or co-infections. Over 80% of ASCC cases are linked to HPV16, with HPV-positive cancers showing better survival, yet despite the vaccine being nearly 100% effective if given before sexual debut, global uptake remains low. Conclusion: Persistent infection with high-risk HPV, especially HPV16, is the main driver of anal carcinogenesis, paralleling cervical disease, and HPV-driven anal cancer is an increasing public health concern. To reduce the incidence and improve outcomes, expanded vaccination, targeted screening, and public awareness are essential. Future efforts should focus on enhancing prevention uptake, clarifying the significance of HPV16 sublineages, and evaluating co-infections and immunity to improve prevention and management.
- Open Access
- 11 September 2025
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 2 (3(47))
A NARRATIVE REVIEW: IMPACT OF DIETARY POLYPHENOLS ON METABOLIC SYNDROME MANAGEMENT
Introduction and purposes: Metabolic syndrome includes central obesity, insulin resistance, dyslipidemia, and hypertension. Studies have explored polyphenols for their potential to prevent or manage these issues through antioxidant and metabolic effects. Materials and Methods: A comprehensive literature review was carried out utilizing PubMed and Google Scholar. The search incorporated keywords such as 'polyphenols', 'metabolic syndrome', 'visceral adipose tissue', 'insulin resistance', 'hypertension', 'atherogenic dyslipidemia'. The search included articles published from 2020 to 2025. Results: Although many studies suggest that polyphenols may help to manage central obesity, the effects of polyphenols on carbohydrate metabolism, blood pressure and lipid profiles are inconsistent and inconclusive. These conflicting results are probably due to small sample sizes and a lack of robust, high-quality human clinical trials. Conclusion: The review indicates a potential connection between dietary polyphenols and the individual elements of MetS, highlighting the need for further investigation in this area. Overall, due to the variability in study design and sample size, conclusions should be interpreted with careful consideration.
- 11 September 2025
- Published by RS Global Sp. z O.O. in International Journal of Innovative Technologies in Social Science
- Vol. 2 (3(47))
Open AccessA NARRATIVE REVIEW: IMPACT OF DIETARY POLYPHENOLS ON METABOLIC SYNDROME MANAGEMENT
Introduction and purposes: Metabolic syndrome includes central obesity, insulin resistance, dyslipidemia, and hypertension. Studies have explored polyphenols for their potential to prevent or manage these issues through antioxidant and metabolic effects. Materials and Methods: A comprehensive literature review was carried out utilizing PubMed and Google Scholar. The search incorporated keywords such as 'polyphenols', 'metabolic syndrome', 'visceral adipose tissue', 'insulin resistance', 'hypertension', 'atherogenic dyslipidemia'. The search included articles published from 2020 to 2025. Results: Although many studies suggest that polyphenols may help to manage central obesity, the effects of polyphenols on carbohydrate metabolism, blood pressure and lipid profiles are inconsistent and inconclusive. These conflicting results are probably due to small sample sizes and a lack of robust, high-quality human clinical trials. Conclusion: The review indicates a potential connection between dietary polyphenols and the individual elements of MetS, highlighting the need for further investigation in this area. Overall, due to the variability in study design and sample size, conclusions should be interpreted with careful consideration.
- Open Access
- 5 April 2025
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 80, 58492
Role of ketamine in treatment-resistant depression
Introduction: Depression, affecting 350 million people globally, is a leading cause of disability. Common symptoms include low mood, sadness, guilt, anxiety, and suicidalthoughts. Current treatments, mostly monoamine-based antidepressants, have limitations such as delayed effects and low efficacy, with over 60% of patients not achieving lasting remission. Ketamine, an NMDA antagonist, has shown rapid antidepressant effects, and research suggests glutamatergic dysfunction plays a role in TRD, highlighting the need for faster, more effective treatments. Current state of knowledge: Ketamine, an NMDA receptor antagonist, has gained attention for its rapid antidepressant effects, particularly in treatment-resistant depression. It works by modulating the glutamatergic system, enhancing synaptic plasticity, and involving other systems like GABA and 5-HT. Clinical trials have shown ketamine's efficacy in reducing depressive symptoms and suicidal ideation within hours, contrasting with traditional antidepressants that take weeks. The intravenous route is most effective, with lower bioavailability in other forms. While ketamine shows promise, its potential for addiction and side effects necessitate careful monitoring. Conclusion: Evidence supports ketamine for treating refractory depression, enhancing neuroplasticity and regulating affective symptoms through anti-inflammatory effects. Variations exist in administration route, bioavailability, and patient age. Common adverse effects include dissociative symptoms and cardiovascular issues, requiring careful monitoring and management.
- 5 April 2025
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 80, 58492
Open AccessRole of ketamine in treatment-resistant depression
Introduction: Depression, affecting 350 million people globally, is a leading cause of disability. Common symptoms include low mood, sadness, guilt, anxiety, and suicidalthoughts. Current treatments, mostly monoamine-based antidepressants, have limitations such as delayed effects and low efficacy, with over 60% of patients not achieving lasting remission. Ketamine, an NMDA antagonist, has shown rapid antidepressant effects, and research suggests glutamatergic dysfunction plays a role in TRD, highlighting the need for faster, more effective treatments. Current state of knowledge: Ketamine, an NMDA receptor antagonist, has gained attention for its rapid antidepressant effects, particularly in treatment-resistant depression. It works by modulating the glutamatergic system, enhancing synaptic plasticity, and involving other systems like GABA and 5-HT. Clinical trials have shown ketamine's efficacy in reducing depressive symptoms and suicidal ideation within hours, contrasting with traditional antidepressants that take weeks. The intravenous route is most effective, with lower bioavailability in other forms. While ketamine shows promise, its potential for addiction and side effects necessitate careful monitoring. Conclusion: Evidence supports ketamine for treating refractory depression, enhancing neuroplasticity and regulating affective symptoms through anti-inflammatory effects. Variations exist in administration route, bioavailability, and patient age. Common adverse effects include dissociative symptoms and cardiovascular issues, requiring careful monitoring and management.
- Open Access
- 30 September 2024
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 23, 54686
The health aspects of skiing
Introduction and Purpose: This article presents a comprehensive analysis of the risks and benefits associated with downhill skiing. The article elucidates the prevalence and etiology of common injuries, while also delineating the salutary effects of engaging in the sport. Methods: A literature search was conducted using PubMed and Google Scholar, focusing on articles from 2019 to 2024, including observational studies, clinical trials, meta-analyses and systematic reviews. State of Knowledge: Skiing is a globally popular winter sport, attracting millions of enthusiasts each year. The sport's combination of outdoor adventure, social activity, and the allure of winter landscapes contribute to its enduring global popularity. Despite its global popularity, skiing carries a significant risk of injury, with knee injuries, particularly ACL sprains, being the most common, especially among women. Despite these risks, alpine skiing offers significant physical health benefits, including improved cardiorespiratory fitness, muscle strength and mental health, making it a beneficial lifelong sport, particularly for older adults. Conclusion: It is notable that while injuries such as ACL sprains and fractures are prevalent, particularly among beginners and those who engage in risk-taking activities, the sport also offers significant health benefits. Alpine skiing has been demonstrated to enhance cardiorespiratory fitness, muscle strength, and mental well-being, thereby conferring significant benefits that extend throughout the lifespan, despite the potential for injury.
- 30 September 2024
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 23, 54686
Open AccessThe health aspects of skiing
Introduction and Purpose: This article presents a comprehensive analysis of the risks and benefits associated with downhill skiing. The article elucidates the prevalence and etiology of common injuries, while also delineating the salutary effects of engaging in the sport. Methods: A literature search was conducted using PubMed and Google Scholar, focusing on articles from 2019 to 2024, including observational studies, clinical trials, meta-analyses and systematic reviews. State of Knowledge: Skiing is a globally popular winter sport, attracting millions of enthusiasts each year. The sport's combination of outdoor adventure, social activity, and the allure of winter landscapes contribute to its enduring global popularity. Despite its global popularity, skiing carries a significant risk of injury, with knee injuries, particularly ACL sprains, being the most common, especially among women. Despite these risks, alpine skiing offers significant physical health benefits, including improved cardiorespiratory fitness, muscle strength and mental health, making it a beneficial lifelong sport, particularly for older adults. Conclusion: It is notable that while injuries such as ACL sprains and fractures are prevalent, particularly among beginners and those who engage in risk-taking activities, the sport also offers significant health benefits. Alpine skiing has been demonstrated to enhance cardiorespiratory fitness, muscle strength, and mental well-being, thereby conferring significant benefits that extend throughout the lifespan, despite the potential for injury.
- Open Access
- 23 August 2024
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 20, 53990
Benefits of bariatric surgery on glycemic control in patients with type 2 diabetes mellitus. A narrative review.
Introduction and purposes: Obesity is a critical global health challenge, closely linked to a range of serious conditions, including metabolic syndrome, insulin resistance, and an increased likelihood of developing type 2 diabetes. Affecting over two billion people worldwide, obesity necessitates a multifaceted approach to treatment, encompassing lifestyle changes, pharmaceutical interventions, and surgical procedures. Among the surgical options, bariatric surgeries such as sleeve gastrectomy (SG) and Roux-en-Y gastric bypass (RYGB) are particularly prominent. Materials and Methods: A systematic literature search was conducted using PubMed and Google Scholar. The search employed terms such as 'glycemia', 'bariatric surgery', ‘metabolic surgery’ 'RYGB', 'diabetes type 2’, ‘Postprandial hyperinsulinemic hypoglycemia’ 'hypoglycemia' ‘dumping syndrome’. Articles published between 2019 and 2024 were included in the search. Results: Bariatric surgery is well-documented for its significant impact on glycemic control and overall physical health, resulting in substantial reductions in both HbA1c levels and BMI. Remarkably, many patients with type 2 diabetes achieve remission of the disease following surgery, regardless of their pre-surgery BMI. However, the enhanced glycemic control achieved through bariatric procedures can also lead to an increased risk of developing postprandial hyperinsulinemic hypoglycemia (PHH). This condition arises as a complication from the surgery, where blood sugar levels drop excessively after meals due to an overproduction of insulin. Conclusion: Despite this potential risk, the overall benefits of bariatric surgery in managing and potentially reversing type 2 diabetes are profound.
- 23 August 2024
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 20, 53990
Open AccessBenefits of bariatric surgery on glycemic control in patients with type 2 diabetes mellitus. A narrative review.
Introduction and purposes: Obesity is a critical global health challenge, closely linked to a range of serious conditions, including metabolic syndrome, insulin resistance, and an increased likelihood of developing type 2 diabetes. Affecting over two billion people worldwide, obesity necessitates a multifaceted approach to treatment, encompassing lifestyle changes, pharmaceutical interventions, and surgical procedures. Among the surgical options, bariatric surgeries such as sleeve gastrectomy (SG) and Roux-en-Y gastric bypass (RYGB) are particularly prominent. Materials and Methods: A systematic literature search was conducted using PubMed and Google Scholar. The search employed terms such as 'glycemia', 'bariatric surgery', ‘metabolic surgery’ 'RYGB', 'diabetes type 2’, ‘Postprandial hyperinsulinemic hypoglycemia’ 'hypoglycemia' ‘dumping syndrome’. Articles published between 2019 and 2024 were included in the search. Results: Bariatric surgery is well-documented for its significant impact on glycemic control and overall physical health, resulting in substantial reductions in both HbA1c levels and BMI. Remarkably, many patients with type 2 diabetes achieve remission of the disease following surgery, regardless of their pre-surgery BMI. However, the enhanced glycemic control achieved through bariatric procedures can also lead to an increased risk of developing postprandial hyperinsulinemic hypoglycemia (PHH). This condition arises as a complication from the surgery, where blood sugar levels drop excessively after meals due to an overproduction of insulin. Conclusion: Despite this potential risk, the overall benefits of bariatric surgery in managing and potentially reversing type 2 diabetes are profound.
- Open Access
- 23 July 2024
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 17, 53070
How should we treat postherpetic neuralgia?
Postherpetic neuralgia (PHN) is the most common long-term complication of varicella-zoster virus (VZV) reactivation. It is characterized primarily by persistent pain more than 90 days after the illness at the site where the rash was. This pain is sharp, burning, stabbing in nature. Postherpetic neuralgia can lead to a reduced quality of life and negatively affect sleep and daily functioning. The first line of treatment is currently conservative methods, which include anticonvulsants, antidepressants, topical lidocaine, as well as opioids and topical capsaicin. If these measures are ineffective, individually tailored interventional methods may be necessary. Among these, botulinum toxin A injection is the most common. Other methods focus on neuromodulation (which is the alteration of nerve activity through targeted delivery of a stimulus) or blocking individual elements of the nervous system.
- 23 July 2024
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 17, 53070
Open AccessHow should we treat postherpetic neuralgia?
Postherpetic neuralgia (PHN) is the most common long-term complication of varicella-zoster virus (VZV) reactivation. It is characterized primarily by persistent pain more than 90 days after the illness at the site where the rash was. This pain is sharp, burning, stabbing in nature. Postherpetic neuralgia can lead to a reduced quality of life and negatively affect sleep and daily functioning. The first line of treatment is currently conservative methods, which include anticonvulsants, antidepressants, topical lidocaine, as well as opioids and topical capsaicin. If these measures are ineffective, individually tailored interventional methods may be necessary. Among these, botulinum toxin A injection is the most common. Other methods focus on neuromodulation (which is the alteration of nerve activity through targeted delivery of a stimulus) or blocking individual elements of the nervous system.